APA (7th ed.) Citation

C, J., M, C., L, N., M, L., J, M., O, E., . . . O, L. (2022). Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial. EClinicalMedicine, 48, 101444. https://doi.org/10.1016/j.eclinm.2022.101444

Chicago Style (17th ed.) Citation

C, Janssen, et al. "Immunogenicity and Reactogenicity of Heterologous and Homologous MRNA-1273 and BNT162b2 Vaccination: A Multicenter Non-inferiority Randomized Trial." EClinicalMedicine 48 (2022): 101444. https://doi.org/10.1016/j.eclinm.2022.101444.

MLA (9th ed.) Citation

C, Janssen, et al. "Immunogenicity and Reactogenicity of Heterologous and Homologous MRNA-1273 and BNT162b2 Vaccination: A Multicenter Non-inferiority Randomized Trial." EClinicalMedicine, vol. 48, 2022, p. 101444, https://doi.org/10.1016/j.eclinm.2022.101444.